Metoclopramide for Migraine: A Dose Finding Study

Completed · Phase 3

Conditions studied: Migraine

In brief

Metoclopramide is an effective intravenous treatment for acute migraine attacks, but we do not know the best dose to administer. This study compares three different doses of metoclorpamide.

Key facts

Study ID

NCT00682734

Run by

Montefiore Medical Center

People needed

349

Starts

2008-04-01

Expected to finish

2010-03-01

Last updated by the study team

2018-05-31

Who can join

Age: 18 and older, up to 69. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• acute migraine

You may not qualify if…

• secondary cause of headache
• lumbar puncture
• allergy or intolerance to study medication

Where it is running

• Montefiore Medical Center — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.